• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中枢神经系统屏障损伤在肌萎缩侧索硬化症中的意义:患者的性别差异。

Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients.

机构信息

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.

UMR 1253 iBrain, Université de Tours, Inserm, 10 Boulevard Tonnellé, 37000 Tours, France.

出版信息

Int J Mol Sci. 2023 Jul 7;24(13):11196. doi: 10.3390/ijms241311196.

DOI:10.3390/ijms241311196
PMID:37446372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10342931/
Abstract

Central nervous system (CNS) barrier impairment has been reported in amyotrophic lateral sclerosis (ALS), highlighting its potential significance in the disease. In this context, we aim to shed light on its involvement in the disease, by determining albumin quotient (QAlb) at the time of diagnosis of ALS in a large cohort of patients. Patients from the university hospital of Tours ( = 307) were included in this monocentric, retrospective study. In total, 92 patients (30%) had elevated QAlb levels. This percentage was higher in males (43%) than in females (15%). Interestingly, QAlb was not associated with age of onset, age at sampling or diagnostic delay. However, we found an association with ALS functional rating scale-revised (ALSFRS-r) at diagnosis but this was significant only in males. The QAlb levels were not linked to the presence of a pathogenic mutation. Finally, we performed a multivariate survival analysis and found that QAlb was significantly associated with survival in male patients (HR = 2.3, 95% CI = 1.2-4.3, = 0.009). A longitudinal evaluation of markers of barrier impairment, in combination with inflammatory biomarkers, could give insight into the involvement of CNS barrier impairment in the pathogenesis of the disease. The gender difference might guide the development of new drugs and help personalise the treatment of ALS.

摘要

中枢神经系统(CNS)屏障损伤已在肌萎缩侧索硬化症(ALS)中报道,强调了其在疾病中的潜在意义。在这种情况下,我们旨在通过在大量患者中确定 ALS 诊断时的白蛋白商(QAlb)来阐明其在疾病中的作用。我们的研究纳入了图尔大学医院的患者(n=307)。共有 92 名患者(30%)的 QAlb 水平升高。男性(43%)的这一比例高于女性(15%)。有趣的是,QAlb 与发病年龄、采样年龄或诊断延迟无关。然而,我们发现 QAlb 与诊断时的肌萎缩侧索硬化功能评定量表修订版(ALSFRS-r)有关,但仅在男性中具有统计学意义。QAlb 水平与致病性突变的存在无关。最后,我们进行了多变量生存分析,发现 QAlb 与男性患者的生存显著相关(HR=2.3,95%CI=1.2-4.3,p=0.009)。对屏障损伤标志物的纵向评估,结合炎症生物标志物,可能有助于深入了解 CNS 屏障损伤在疾病发病机制中的作用。性别差异可能为开发新的药物提供指导,并有助于 ALS 的个体化治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/3a2e8a6621fb/ijms-24-11196-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/9e71eaa6ee05/ijms-24-11196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/d428836694f8/ijms-24-11196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/c9ca6ad25d62/ijms-24-11196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/3a2e8a6621fb/ijms-24-11196-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/9e71eaa6ee05/ijms-24-11196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/d428836694f8/ijms-24-11196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/c9ca6ad25d62/ijms-24-11196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cae/10342931/3a2e8a6621fb/ijms-24-11196-g004.jpg

相似文献

1
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients.中枢神经系统屏障损伤在肌萎缩侧索硬化症中的意义:患者的性别差异。
Int J Mol Sci. 2023 Jul 7;24(13):11196. doi: 10.3390/ijms241311196.
2
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.年龄增长和男性性别与血脑屏障功能障碍的频率增加独立相关,可通过白蛋白商数来评估。
Fluids Barriers CNS. 2020 Feb 5;17(1):14. doi: 10.1186/s12987-020-0173-2.
3
Associations of cerebrospinal fluid profiles with severity and mortality risk of amyotrophic lateral sclerosis.脑脊液特征与肌萎缩侧索硬化症严重程度及死亡风险的关联。
Front Neurosci. 2024 May 15;18:1375892. doi: 10.3389/fnins.2024.1375892. eCollection 2024.
4
Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients.脑脊液同型半胱氨酸水平升高与肌萎缩侧索硬化症患者的血脑屏障破坏有关。
Neurol Sci. 2020 Jul;41(7):1865-1872. doi: 10.1007/s10072-020-04292-x. Epub 2020 Feb 21.
5
Choroid plexus enlargement in amyotrophic lateral sclerosis patients and its correlation with clinical disability and blood-CSF barrier permeability.肌萎缩侧索硬化症患者脉络丛增大及其与临床残疾和血脑屏障通透性的相关性。
Fluids Barriers CNS. 2024 Apr 17;21(1):36. doi: 10.1186/s12987-024-00536-6.
6
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis.脑脊液蛋白和白蛋白升高预示着脊髓肌萎缩预后不良。
Int J Mol Sci. 2022 Sep 21;23(19):11063. doi: 10.3390/ijms231911063.
7
Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.18 氟脱氧葡萄糖正电子发射断层扫描在肌萎缩侧索硬化症中的价值:一项前瞻性研究。
JAMA Neurol. 2014 May;71(5):553-61. doi: 10.1001/jamaneurol.2014.62.
8
Blood-Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis.血脑屏障破坏与肌萎缩侧索硬化症的疾病侵袭性无关。
Front Neurosci. 2021 Oct 29;15:656456. doi: 10.3389/fnins.2021.656456. eCollection 2021.
9
Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia.血脑屏障功能障碍与髓鞘碱性蛋白在伴或不伴额颞叶痴呆的肌萎缩侧索硬化症存活中的作用
Neurol Sci. 2022 May;43(5):3201-3210. doi: 10.1007/s10072-021-05731-z. Epub 2021 Nov 26.
10
Longitudinal imaging in mutation carriers: Relationship to phenotype.突变携带者的纵向成像:与表型的关系。
Neuroimage Clin. 2016 Oct 22;12:1035-1043. doi: 10.1016/j.nicl.2016.10.014. eCollection 2016.

引用本文的文献

1
Restoring brain barriers: an innovative approach for treating neurological disorders.恢复脑屏障:一种治疗神经系统疾病的创新方法。
Fluids Barriers CNS. 2025 Jul 10;22(1):72. doi: 10.1186/s12987-025-00688-z.
2
Global, regional, and national burden of neuroblastoma and peripheral nervous system tumours in individuals aged over 60 from 1990 to 2021: a trend analysis of global burden of disease study.1990年至2021年60岁以上人群神经母细胞瘤和周围神经系统肿瘤的全球、区域和国家负担:全球疾病负担研究的趋势分析
J Health Popul Nutr. 2025 Mar 17;44(1):78. doi: 10.1186/s41043-025-00810-9.
3
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach.

本文引用的文献

1
Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients.脑脊髓液/血清白蛋白比值与肌萎缩侧索硬化症表型的关系:328 例患者的回顾性研究。
Neurol Sci. 2023 May;44(5):1679-1685. doi: 10.1007/s10072-023-06604-3. Epub 2023 Jan 17.
2
Altered Blood-Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症C9orf72六核苷酸重复扩增小鼠模型中血脑屏障动力学的改变
Pharmaceutics. 2022 Dec 14;14(12):2803. doi: 10.3390/pharmaceutics14122803.
3
C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.
肌萎缩侧索硬化症生物标志物的研究进展:病理生理学方法。
Int J Mol Sci. 2024 Oct 10;25(20):10900. doi: 10.3390/ijms252010900.
4
NX210c drug candidate peptide strengthens mouse and human blood-brain barriers.NX210c 候选药物肽增强了小鼠和人类的血脑屏障。
Fluids Barriers CNS. 2024 Sep 27;21(1):76. doi: 10.1186/s12987-024-00577-x.
5
Brain-body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis.大脑-身体机制导致肌萎缩侧索硬化症的性别二态性。
Nat Rev Neurol. 2024 Aug;20(8):475-494. doi: 10.1038/s41582-024-00991-7. Epub 2024 Jul 4.
6
Associations of cerebrospinal fluid profiles with severity and mortality risk of amyotrophic lateral sclerosis.脑脊液特征与肌萎缩侧索硬化症严重程度及死亡风险的关联。
Front Neurosci. 2024 May 15;18:1375892. doi: 10.3389/fnins.2024.1375892. eCollection 2024.
C9orf72 重复长度可能会影响痴呆症患者的临床亚型。
Neurobiol Dis. 2022 Dec;175:105927. doi: 10.1016/j.nbd.2022.105927. Epub 2022 Nov 13.
4
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis.脑脊液蛋白和白蛋白升高预示着脊髓肌萎缩预后不良。
Int J Mol Sci. 2022 Sep 21;23(19):11063. doi: 10.3390/ijms231911063.
5
Amyotrophic lateral sclerosis.肌萎缩性侧索硬化症。
Lancet. 2022 Oct 15;400(10360):1363-1380. doi: 10.1016/S0140-6736(22)01272-7. Epub 2022 Sep 15.
6
Taking Advantages of Blood-Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?利用血脑屏障或脊髓屏障的改变,或恢复这些屏障以优化肌萎缩侧索硬化症的治疗?
J Pers Med. 2022 Jun 29;12(7):1071. doi: 10.3390/jpm12071071.
7
Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis.被突破的屏障:肌萎缩侧索硬化症血-中枢神经系统屏障病理学的范围综述
Front Cell Neurosci. 2022 Mar 31;16:851563. doi: 10.3389/fncel.2022.851563. eCollection 2022.
8
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.对肌萎缩侧索硬化症复杂遗传学和病理生理学的新见解。
Lancet Neurol. 2022 May;21(5):465-479. doi: 10.1016/S1474-4422(21)00414-2. Epub 2022 Mar 22.
9
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的炎症的基于血液的生物标志物。
Mol Neurodegener. 2022 Jan 24;17(1):11. doi: 10.1186/s13024-022-00515-1.
10
Altered blood-brain barrier and blood-spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety.肌萎缩侧索硬化症中血脑屏障和血脊髓屏障动力学的改变:对药物疗效和安全性的影响。
Br J Pharmacol. 2022 Jun;179(11):2577-2588. doi: 10.1111/bph.15802. Epub 2022 Feb 7.